Kaken Pharmaceutical will hand Alumis $40 million in the near term for the rights to develop a late-stage tyrosine kinase 2 ...

Get real-time updates on Japan vs Saudi Arabia live coverage minute by minute of the match, score and result online, stream ...

The total mobile service revenue in Japan is poised to increase at a compound annual growth rate (CAGR) of 3 per cent from ...

ORIX Corporation India's strategic investment of Rs 300 crore from its Japanese parent ORIX Corporation aims to bolster its ...

Tokyo, Japan and Cambridge, UK, 25 March 2025 - Nxera Pharma Co., Ltd. ("Nxera" or "the Company"; TSE 4565) announces that its partner Tempero Bio, Inc. has initiated a Phase 2 trial of TMP-301, a pot ...